tiprankstipranks
Insight Molecular Diagnostics (IMDX)
NASDAQ:IMDX
US Market
IMDX
Insight Molecular Diagnostics
RESEARCH TOOLSreports

Insight Molecular Diagnostics (IMDX) Financial Statements

Compare
432 Followers

Insight Molecular Diagnostics Financial Overview

Insight Molecular Diagnostics's market cap is currently $132.12M. The company's EPS TTM is $-0.72; its P/E ratio is -4.55; Insight Molecular Diagnostics is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Mar 23Dec 21
Income Statement
Total Revenue$ 4.05M$ 1.88M$ 1.50M$ 958.00K$ 2.20M
Gross Profit$ 2.30M$ 740.00K$ 413.00K$ -18.00K$ 1.42M
Operating Income$ -51.12M$ -61.04M$ -25.14M$ -18.00M$ -53.73M
EBITDA$ -51.12M$ -59.02M$ -23.12M$ -13.31M$ -48.46M
Net Income$ -50.22M$ -60.66M$ -27.78M$ -72.90M$ -64.10M
Balance Sheet
Cash & Short-Term Investments$ 11.58M$ 8.64M$ 9.43M$ 20.43M$ 33.85M
Total Assets$ 25.76M$ 35.08M$ 74.89M$ 100.09M$ 159.56M
Total Debt$ 3.50M$ 3.66M$ 2.87M$ 3.54M$ 5.68M
Net Debt$ -8.09M$ -4.97M$ -6.56M$ -16.45M$ -27.27M
Total Liabilities$ 57.22M$ 47.35M$ 54.42M$ 60.50M$ 94.35M
Stockholders' Equity$ -31.46M$ -12.27M$ 20.47M$ 39.59M$ 65.22M
Cash Flow
Free Cash Flow$ -22.18M$ -21.23M$ -23.61M$ -49.91M$ -38.19M
Operating Cash Flow$ -22.18M$ -20.71M$ -23.32M$ -45.57M$ -35.94M
Investing Cash Flow$ -3.19M$ -512.00K$ -932.00K$ -4.34M$ -13.96M
Financing Cash Flow$ 28.07M$ 20.43M$ 12.19M$ 35.81M$ 78.36M
Currency in USD

Insight Molecular Diagnostics Earnings and Revenue History

Income Statement >

Insight Molecular Diagnostics Debt to Assets

Balance Sheet >

Insight Molecular Diagnostics Cash Flow

Cash Flow >

Insight Molecular Diagnostics Forecast EPS vs Actual EPS

Earnings >